ATS 2018 International Conference - Mobile

Long-Term Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease Treated with Twice-Daily Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: Results from the TORCH Study [Board No. P1346]

Location: Board no. P1346

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Ian Naya

BSc
GSK

Maurice T. Driessen

PhD
GSK

Nancy Risebrough

BA
ICON

Victoria Paly

MHS
ICON

Andrew Briggs

DPhil
ICON

Afisi Segun. Ismaila

PhD
GlaxoSmithKline

Necdet Gunsoy

PhD
GSK

View Abstract

Long-Term Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease Treated with Twice-Daily Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: Results from the TORCH Study

Parent Sessions

B33 - COPD: MAINTENANCE THERAPY
05-21-2018 9:15 AM - 4:15 PM